47 false false false false false false false false false false true false false true false true true No description of principal activity 2023-06-01 Sage Accounts Production Advanced 2023 - FRS102_2023 350,000 210,000 35,000 245,000 105,000 140,000 xbrli:pure xbrli:shares iso4217:GBP 08053341 2023-06-01 2024-05-31 08053341 2024-05-31 08053341 2023-05-31 08053341 2022-06-01 2023-05-31 08053341 2023-05-31 08053341 2022-05-31 08053341 core:PlantMachinery 2023-06-01 2024-05-31 08053341 bus:Director2 2023-06-01 2024-05-31 08053341 core:NetGoodwill 2023-05-31 08053341 core:NetGoodwill 2024-05-31 08053341 core:PlantMachinery 2024-05-31 08053341 core:WithinOneYear 2024-05-31 08053341 core:WithinOneYear 2023-05-31 08053341 core:AfterOneYear 2024-05-31 08053341 core:AfterOneYear 2023-05-31 08053341 core:ShareCapital 2024-05-31 08053341 core:ShareCapital 2023-05-31 08053341 core:RetainedEarningsAccumulatedLosses 2024-05-31 08053341 core:RetainedEarningsAccumulatedLosses 2023-05-31 08053341 core:NetGoodwill 2023-06-01 2024-05-31 08053341 core:NetGoodwill 2023-05-31 08053341 bus:SmallEntities 2023-06-01 2024-05-31 08053341 bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 08053341 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 08053341 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 08053341 bus:FullAccounts 2023-06-01 2024-05-31
COMPANY REGISTRATION NUMBER: 08053341
Eager Health Ltd
Filleted Unaudited Financial Statements
31 May 2024
Eager Health Ltd
Statement of Financial Position
31 May 2024
2024
2023
Note
£
£
£
Fixed assets
Intangible assets
5
105,000
140,000
Current assets
Debtors
7
143,699
20,681
Cash at bank and in hand
35,802
174
---------
--------
179,501
20,855
Creditors: amounts falling due within one year
8
404,443
318,217
---------
---------
Net current liabilities
224,942
297,362
---------
---------
Total assets less current liabilities
( 119,942)
( 157,362)
Creditors: amounts falling due after more than one year
9
36,837
35,401
---------
---------
Net liabilities
( 156,779)
( 192,763)
---------
---------
Capital and reserves
Called up share capital
120
120
Profit and loss account
( 156,899)
( 192,883)
---------
---------
Shareholder deficit
( 156,779)
( 192,763)
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the income statement has not been delivered.
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Eager Health Ltd
Statement of Financial Position (continued)
31 May 2024
These financial statements were approved by the board of directors and authorised for issue on 19 September 2024 , and are signed on behalf of the board by:
Mr Manoj Gohil
Director
Company registration number: 08053341
Eager Health Ltd
Notes to the Financial Statements
Year ended 31 May 2024
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 136 St Albans Road, Watford, WD24 4FT, London.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102 and has applied the required disclosure exemptions available
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Goodwill
-
Over 10 years
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant & machinery
-
25% straight line
Equipment
-
25 % straight line
4. Employee numbers
The average number of persons employed by the company during the year amounted to 47 (2023: 52 ).
5. Intangible assets
Goodwill
£
Cost
At 1 June 2023 and 31 May 2024
350,000
---------
Amortisation
At 1 June 2023
210,000
Charge for the year
35,000
---------
At 31 May 2024
245,000
---------
Carrying amount
At 31 May 2024
105,000
---------
At 31 May 2023
140,000
---------
6. Tangible assets
Plant and machinery
Equipment
Total
£
£
£
Cost
At 1 June 2023 and 31 May 2024
5,882
16,266
22,148
-------
--------
--------
Depreciation
At 1 June 2023 and 31 May 2024
5,882
16,266
22,148
-------
--------
--------
Carrying amount
At 31 May 2024
-------
--------
--------
At 31 May 2023
-------
--------
--------
7. Debtors
2024
2023
£
£
Trade debtors
73,524
35,001
Other debtors
70,175
( 14,320)
---------
--------
143,699
20,681
---------
--------
8. Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
25,624
24,413
Trade creditors
42,038
32,738
Corporation tax
19,746
Social security and other taxes
1,790
3,929
Deposit received
43,685
43,685
Other creditors
271,560
213,452
---------
---------
404,443
318,217
---------
---------
9. Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
36,837
35,401
--------
--------
10. Financial instruments
There are no financial instruments requiring disclosure.
11. Director's advances, credits and guarantees
Other than as disclosed in creditors due within one year, there are no other material transactions with the directors.
12. Related party transactions
No transactions with related parties were undertaken such as are required to be disclosed under Financial Reporting Standard 102.